| 摘要 |
<p>Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.</p> |
| 申请人 |
SUMMIT CORPORATION PLC;JOHNSON, PETER DAVID;VICKERS, RICHARD;WILSON, FRANCIS XAVIER;DORGAN, COLIN RICHARD;DE MOOR, OLIVIER;WREN, STEPHEN PAUL;VAN WELL, RENATE |
发明人 |
JOHNSON, PETER DAVID;VICKERS, RICHARD;WILSON, FRANCIS XAVIER;DORGAN, COLIN RICHARD;DE MOOR, OLIVIER;WREN, STEPHEN PAUL;VAN WELL, RENATE |
